Therefore, a further lung sampling in SSc-ILD patients with less severe/progressed lung involvement, should be an additional step to evaluate possible differences in the presence of TLR4+M2 macrophages in early versus advanced disease. The gene discussed is TLR4; the disease is systemic sclerosis.